India's Serum Institute takes 50% stake in drug vial maker Schott Kaisha
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
BENGALURU - Serum Institute of India, the world's largest vaccine maker by production volume, has taken a 50% stake in Indian drug vial maker Schott Kaisha, the companies said in a statement https://bit.ly/3AIBLvS on Tuesday.
Serum Institute was already a customer of Schott Kaisha, using their vials, ampoules and syringes to store vaccines including the COVID-19 vaccine Covishield. The companies did not provide any further details on the deal.
